Lifecore Biomedical, Inc. \De\ Q2 FY2025 Earnings Call

Lifecore Biomedical, Inc. \De\ (LFCR)

Earnings Call FY2025 Q2 Call date: 2025-01-02 Concluded

Quarter scorecard

Revenue

$32.56M

+8% YoY

Diluted EPS

$-0.25

-164.1% YoY

Gross margin

34.0%

+1.0 pp YoY

Net income

-$6.57M

-146.2% YoY

Contract Development and Manufacturing Organization $25.61M

+8.2%

HA Manufacturing $6.95M

+7.4%